PDF
Word
This version of the form is not currently in use and is provided for reference only. Download this version of
Form HLTH5338
for the current year.
Form HLTH5338 Special Authority Request - Dalteparin / Enoxaparin (Biosimilar) / Nadroparin / Tinzaparin Low Molecular Weight Heparin - British Columbia, Canada
Form HLTH5338 Special Authority Request - Dalteparin/Enoxaparin (Biosimilar)/Nadroparin/Tinzaparin Low Molecular Weight Heparin is used in British Columbia, Canada to request special authorization for the use of specific medications known as low molecular weight heparins, such as Dalteparin, Enoxaparin (Biosimilar), Nadroparin, and Tinzaparin. These medications are used for the prevention and treatment of blood clots.
The Form HLTH5338 Special Authority Request for Dalteparin/Enoxaparin (Biosimilar)/Nadroparin/Tinzaparin Low Molecular Weight Heparin in British Columbia, Canada is typically filed by the patient's healthcare provider or doctor.
FAQ
Q: What is a Special Authority Request?
A: A Special Authority Request is a process through which certain medications may be covered by the government of British Columbia, Canada.
Q: What is Dalteparin/Enoxaparin (Biosimilar)/Nadroparin/Tinzaparin?
A: Dalteparin/Enoxaparin (Biosimilar)/Nadroparin/Tinzaparin are different types of Low Molecular Weight Heparin medications used for preventing blood clots.
Q: Why would someone need a Special Authority Request for these medications?
A: A Special Authority Request may be required for Dalteparin/Enoxaparin (Biosimilar)/Nadroparin/Tinzaparin to obtain coverage by the government in British Columbia. This is typically due to the specific criteria set by the province for coverage.
Q: Who can submit a Special Authority Request?
A: A healthcare professional, such as a doctor or pharmacist, can submit a Special Authority Request on behalf of the patient.
Q: What information is needed for a Special Authority Request?
A: The Special Authority Request form typically requires information such as the patient's personal information, medical history, and the specific medication being requested.
Q: How long does it take for a Special Authority Request to be processed?
A: Processing times for Special Authority Requests can vary, but it is important to submit the request in advance to allow for sufficient processing time.
Q: What happens if a Special Authority Request is approved?
A: If a Special Authority Request is approved, the medication (such as Dalteparin/Enoxaparin (Biosimilar)/Nadroparin/Tinzaparin) may be covered by the government for the patient.
Q: What happens if a Special Authority Request is denied?
A: If a Special Authority Request is denied, the patient may need to explore alternative options for obtaining the medication.
Q: Can I appeal a denied Special Authority Request?
A: Yes, it is possible to appeal a denied Special Authority Request by providing additional information or supporting documentation.
